GlassScriptPhysician profile
John L Mccarville
NPI 1831192624
$16,778.24
in general payments reported to CMS, 2019-2025
14 companies · $66.50 in 2025
The $66.50 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11K · 2021: $171 · 2022: $82.51 · 2023: $170 · 2024: $5,748 · 2025: $66.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $1,103 · Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $1,102.95 |
| Food and Beverage | $381.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $10,512.00 | 2020 | |
| Intuitive Surgical, INC. | $5,687.33 | 2024 | |
| Abbvie INC. | $237.43 | 2021-2022 | |
| Astellas Pharma US INC | $81.55 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $71.21 | 2023-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Novo Nordisk INC | $33.74 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Medtronic, INC. | $29.67 | 2023 | Ligasure |
| Therapeuticsmd, INC. | $28.73 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $24.36 | 2025 | Exparel |
| Becton, Dickinson and Company | $15.83 | 2021 | |
| Lilly USA, LLC | $15.65 | 2023 | Mounjaro |
| Kowa Pharmaceuticals America, INC. | $14.76 | 2023 | Livalo, Seglentis |
| Minerva Surgical, INC | $13.03 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccarville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.